These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 30346443)

  • 1. [Eye as an object of investigation of cognitive impairment in Parkinson's disease].
    Litvinenko IV; Dynin PS; Trufanov AG; Gimadutdinov RF; Maltsev DS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(6. Vyp. 2):105-114. PubMed ID: 30346443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of retinal changes in idiopathic Parkinson's disease using high-resolution optical coherence tomography and heidelberg retina tomography.
    Bittersohl D; Stemplewitz B; Keserü M; Buhmann C; Richard G; Hassenstein A
    Acta Ophthalmol; 2015 Nov; 93(7):e578-84. PubMed ID: 26267660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the retinal nerve fiber and ganglion cell - Inner plexiform layer by optical coherence tomography in Parkinson's patients.
    Ucak T; Alagoz A; Cakir B; Celik E; Bozkurt E; Alagoz G
    Parkinsonism Relat Disord; 2016 Oct; 31():59-64. PubMed ID: 27423922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photoreceptor layer thinning in idiopathic Parkinson's disease.
    Roth NM; Saidha S; Zimmermann H; Brandt AU; Isensee J; Benkhellouf-Rutkowska A; Dornauer M; Kühn AA; Müller T; Calabresi PA; Paul F
    Mov Disord; 2014 Aug; 29(9):1163-70. PubMed ID: 24789530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinal nerve fiber layer thinning: a window into rapid eye movement sleep behavior disorders in Parkinson's disease.
    Yang ZJ; Wei J; Mao CJ; Zhang JR; Chen J; Ji XY; Liu JY; Shen Y; Xiong KP; Huang JY; Yang YP; Liu CF
    Sleep Breath; 2016 Dec; 20(4):1285-1292. PubMed ID: 27259748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Progressive Visual Dysfunction and Retinal Degeneration in Patients With Parkinson's Disease.
    Satue M; Rodrigo MJ; Obis J; Vilades E; Gracia H; Otin S; Fuertes MI; Alarcia R; Crespo JA; Polo V; Larrosa JM; Pablo LE; Garcia-Martin E
    Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):1151-1157. PubMed ID: 28208185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A clinical study of changes in retina and visual field in patients with early Parkinson's disease].
    Li L; Ji X; Mao C; Chen Y; Guo S; Li S; Liu C
    Zhonghua Nei Ke Za Zhi; 2015 Jun; 54(6):521-4. PubMed ID: 26359014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectral domain OCT can differentiate the retinal morphological changes of patients with Parkinson's disease in clinical middle stages.
    Huang J; Wang Q; Li K; Zhang Q; Xu G; Liu J; Zhang J; Niu T; Zhang Q; Luo W
    Neurol Sci; 2020 Jul; 41(7):1909-1912. PubMed ID: 31974797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optical coherence tomography in Parkinson's disease: is the retina a biomarker?
    Lee JY; Ahn J; Kim TW; Jeon BS
    J Parkinsons Dis; 2014; 4(2):197-204. PubMed ID: 24518436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optical coherence tomography findings in Parkinson's disease.
    Aydin TS; Umit D; Nur OM; Fatih U; Asena K; Nefise OY; Serpil Y
    Kaohsiung J Med Sci; 2018 Mar; 34(3):166-171. PubMed ID: 29475464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a prediction formula of Parkinson disease severity by optical coherence tomography.
    Jiménez B; Ascaso FJ; Cristóbal JA; López del Val J
    Mov Disord; 2014 Jan; 29(1):68-74. PubMed ID: 24458320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinal vessel diameter obtained by optical coherence tomography is spared in Parkinson's disease.
    Gulmez Sevim D; Unlu M; Sonmez S; Gultekin M; Karaca C; Ozturk Oner A
    Int Ophthalmol; 2019 Apr; 39(4):813-819. PubMed ID: 29492727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of spectral-domain optical coherence tomography determined ganglion cell complex parameters and disease severity in Parkinson's disease.
    Bayhan HA; Aslan Bayhan S; Tanık N; Gürdal C
    Curr Eye Res; 2014 Nov; 39(11):1117-22. PubMed ID: 24655112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scanning laser polarimetry and spectral domain optical coherence tomography for the detection of retinal changes in Parkinson's disease.
    Stemplewitz B; Keserü M; Bittersohl D; Buhmann C; Skevas C; Richard G; Hassenstein A
    Acta Ophthalmol; 2015 Dec; 93(8):e672-7. PubMed ID: 26066643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinal nerve fiber layer thickness and visual hallucinations in Parkinson's Disease.
    Lee JY; Kim JM; Ahn J; Kim HJ; Jeon BS; Kim TW
    Mov Disord; 2014 Jan; 29(1):61-7. PubMed ID: 23775932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinal nerve fiber layer thickness and neuropsychiatric manifestations in systemic lupus erythematosus.
    Shulman S; Shorer R; Wollman J; Dotan G; Paran D
    Lupus; 2017 Nov; 26(13):1420-1425. PubMed ID: 28385127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of levodopa on retina in Parkinson disease.
    Sen A; Tugcu B; Coskun C; Ekinci C; Nacaroglu SA
    Eur J Ophthalmol; 2014; 24(1):114-9. PubMed ID: 23828323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual dysfunction and its correlation with retinal changes in patients with Parkinson's disease: an observational cross-sectional study.
    Polo V; Satue M; Rodrigo MJ; Otin S; Alarcia R; Bambo MP; Fuertes MI; Larrosa JM; Pablo LE; Garcia-Martin E
    BMJ Open; 2016 May; 6(5):e009658. PubMed ID: 27154474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optical coherence tomography as a tool to evaluate retinal changes in Parkinson's disease.
    Mailankody P; Battu R; Khanna A; Lenka A; Yadav R; Pal PK
    Parkinsonism Relat Disord; 2015 Oct; 21(10):1164-9. PubMed ID: 26297381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Choroidal and Retinal Thickness Changes in Parkinson's Disease Using Spectral Domain Optical Coherence Tomography.
    Moschos MM; Chatziralli IP
    Semin Ophthalmol; 2018; 33(4):494-497. PubMed ID: 28394663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.